Psychedelic mushrooms are a substance that has generated a lot of interest in recent years for their potential therapeutic benefits in treating various mental health conditions. In this article, we tell you how Oregon has become the first state in the United States to legalize the use of psilocybin, the active ingredient in these mushrooms, and what this breakthrough means for science and society. What is psilocybin and how does it work?
All the information in this article has been taken from the Essential Guide to the Psychedelic Renaissance, now available on Amazon. What is addiction? Psychedelics and addiction Take a look at our social networks to keep updated: ⇦ Back All the information in this article has been taken from the Essential Guide to the Psychedelic Renaissance, now available on Amazon.
Source of the original text: https://pharmacy.unc.edu/directory/denichol/ Take a look at our social networks to keep updated: ⇦ Back David Earl Nichols is an American pharmacologist and medicinal chemist. Formerly the Robert C. and Charlotte P. Anderson Chair of Pharmacology at Purdue University, Nichols has worked in the field of psychoactive drugs since 1969.
All the information in this article has been taken from the Essential Guide to the Psychedelic Renaissance, now available on Amazon. Ketamine in modern medicine Consumption and dosage of Ketamine Take a look at our social networks to keep updated: ⇦ Back All the information in this article has been taken from the Essential Guide to the Psychedelic Renaissance, now available on Amazon.
The American Association on Aging has published an article examining the therapeutic potential of psychedelics for the aging population. According to the World Health Organization, mental disorders are common among older adults and affect approximately 15% of those over the age of 60. The National Council on Aging reports that 80% of adults over the age of 65 suffer from at least one chronic illness, while 68% suffer from two or more, which can exacerbate mental health problems.
Original text: https://hopkinspsychedelic.org/richards Take a look at our social networks to keep updated: ⇦ Back William A. Richards, also known as Bill Richards, is a psychologist in the Department of Psychiatry at the Johns Hopkins University School of Medicine, Bayview Medical Center, a consultant/trainer at psychedelic research centers internationally, a professor in the Psychedelic Therapy and Research Program at the California Institute of Integral Studies, and also a clinician in private practice in Baltimore.
As of July 1, Australia is preparing for a significant change in the way mental illness will be addressed. The Therapeutic Goods Administration (TGA) has given its approval to allow drugs containing psychedelic substances such as psilocybin, found in hallucinogenic mushrooms, and MDMA, commonly known as ecstasy, to be prescribed by licensed psychiatrists. The use of MDMA will be allowed to treat post-traumatic stress syndrome, while psilocybin will be allowed for depression if other therapeutic approaches fail to achieve improvement.
A new research article in the Journal of Psychopharmacology provides information on the psychological effects of psilocybin in people with bipolar disorder. The results show that although many of these individuals found psilocybin use beneficial, others experienced negative side effects, such as manic symptoms. The use of psilocybin as a therapy for depression is becoming increasingly popular due to its positive results in recent studies. As developed in the Psychonaut’s Guide collection, there is growing evidence that, when used in conjunction with supportive therapy, the ingestion of certain psychedelic compounds can improve the mental health of individuals with various mental disorders.
Virtual reality (VR) is an emerging technology that is increasingly being used in a variety of fields, from entertainment to, more recently, medicine. Within the medical field, in recent years, there has been a growing interest in using VR to recreate experiences with psychedelics, with the aim of investigating their therapeutic effects and improving the understanding of how these substances affect the brain and human behavior as a substitute for the original substances.
Original text source: https://maps.org/people/rick-doblin/ Take a look at our social networks to keep updated: ⇦ Back Born in 1953, Doblin grew up in a conservative Jewish family in the Chicago suburbs. He is the first of four children of pediatrician Morton Doblin and schoolteacher Arline Doblin. He has three younger siblings, Bruce, Sharon and Stuart Doblin.
Germany’s Federal Ministry of Education and Research (BMBF) has granted €2.6m to a study investigating the potential effectiveness of psilocybin as an antidepressant treatment for people who cannot tolerate conventional treatments. The “Efficacy and safety of Psilocybin in treatment-resistant major depression” (EpisoDE) study was launched by the Central Institute for Mental Health (CIMH) Mannheim in 2021. The purpose of this study is to determine whether psilocybin is an effective treatment for people with severe depression.
How can psychedelics help with mental disorders? For that we should first ask ourselves what mental disorders consist of. Simplistically, we could say that when there is a disconnect between our higher models of the world and reality, mental disorders such as depression and addictions occur. Our overactive default network (DMN) filters information in an unhealthy way, controlling how we think, behave and see the world. This limits our ability to relate to situations realistically, reinforcing harmful patterns rather than allowing us to change.
Last Thursday the Psychonaut Guides book series was presented in Mexico City, including the three main titles in Spanish: the Essential Guide to the Psychedelic Renaissance, Your brain on psychedelics and Psychedelics and mental health. The Psychonaut’s Guides are updated and scientifically based guides to discover and explore the exciting world of psychedelic substances, their potential and applications that had already made their appearance in Spain. Now, however, this collection aimed at the growing world of psychonauts and the new psychedelic culture, necessary to understand the neuroscience, pharmacology and applications of psychedelics will also be available in Mexico.
Source: https://www.beckleyfoundation.org/amanda-feilding/ Take a look at our social networks to keep updated: ⇦ Back David Nutt is currently Edmond J. Safra Professor of Neuropsychopharmacology and Director of the Neuropsychopharmacology Unit in the Division of Brain Sciences. After joining Bristol Grammar School, David obtained an open scholarship to Downing College, Cambridge and then completed his medical training at Guy’s Hospital, London, continuing in neurology to MRCP.
The state has become the second in the country to pass such a measure, after Oregon did so in 2020. Voters in the U.S. state of Colorado have approved by popular vote a measure to legalize the use and cultivation of several natural psychedelics and psilocybin therapy in licensed facilities. Colorado has thus become the second state in the country to pass such a measure, after Oregon voters succeeded in 2020.
Esketamine will be prescribed to at least 30% of patients who do not respond to two conventional treatments. The China Antiviral Treatment Association (JILA) group has announced that the pricing of esketamine nasal spray, registered by Johnson & Johnson under the name “Spravato”, in combination with other antidepressants, reaching an agreement for the marketing of the first ketamine-based drug in Spain and Europe. The aim of this drug is to be used in approximately 30% of cases, since the combination of traditional antidepressants has a limited clinical benefit, as the increasing number of suicides in people with diagnosed depression.
Nearly half of Americans support legalization of psychedelics for mental health, according to a new poll by VeryWellMind 45% of Americans say they support legalization of some legal psychedelic substances for treatment of mental illness, provided that they are supervised by a medical doctor, mental health professional, or other health care provider. The results from this new study on these substances coincide with growing pressure to study the deadly effects of these substances and take steps to protect people from their potentially damaging effects.
Text extracted from: https://psychedelicreview.com/person/torsten-passie/ Take a look at our social networks to keep updated: ⇦ Back Dr. Torsten Passie (born 1961) is a German psychiatrist, professor at the Hannover Medical School and internationally renowned scientific expert on altered states of consciousness. He received his degree in philosophy and sociology from the Leibniz University of Hannover and his doctorate from the Hannover Medical School.
The Psychedelic Renaissance is in full swing. Every few weeks we hear in national and international media about new studies, scientific advances and political debates and measures to legalize or decriminalize its use. But when did the clinical use of psychedelics begin to permeate mainstream culture? Was it through the media, or did it come from elsewhere? In this article we are going to analyze it. 1. Psychedelics may be the future The psychedelic revolution is coming.
Text extracted from: https://www.beckleyfoundation.org/amanda-feilding/ Take a look at our social networks to keep updated: ⇦ Back With this article we open a section in the page, “Meet:“. This section aims to divulge about some of the most important figures within the scientific advancement and the so-called psychedelic renaissance. For this purpose, we have chosen as our first personality to highlight Amand Feilding.
The book Essential Guide to the Psychedelic Renaissance by Antón Gómez-Escolar, tells us how in 1938 Albert Hofmann, after having accidentally absorbed an infinitesimal amount of a compound he had just synthesized in his laboratio, returned home experiencing a cognitive sensation out of reality. He had just discovered the effects of LSD. Between this event, celebrated in the psychedelic community as the beginning of all that was to come, and the famous summer of love and counterculture, three decades were to pass.
A new study published in the journal Biological Psychiatry appears to conclude that psychedelic-assisted therapy may be an effective and long-lasting treatment for symptoms related to anxiety and depression. The results, measured using scientifically validated and widely used questionnaires, appear to have been much better than the researchers expected. To conduct the study, a team of Swiss researchers administered twenty participants diagnosed with a life-threatening illness, and twenty-two other participants with a mental disorder, significant amounts of LSD under the supervision of a trained therapist.
A few weeks ago we told you how Portugal became a reference in the legal issue and psychedelics two decades ago, decriminalizing their use. At the end of the article, we wished that the rest of the countries would look at this type of measures and start to expand. Well, this morning we woke up to fantastic news: San Francisco has decriminalized psychedelics. Psychedelics such as psilocybin and ayahuasca will be “among the lowest priorities” for law enforcement.
As Antón Gómez-Escolar tells us at the beginning of the second chapter of the Essential Guide to the Psychedelic Renaissance, “psychoactive substances are those that when introduced into the organism by any route (oral, nasal, intramuscular, intravenous) exert a direct effect on the Central Nervous System, causing specific changes to its functions (pain, mood, perceptions, etc), as for example do alcohol, caffeine, anxiolytics, antidepressants, some analgesics,. . and drugs.”
The Psychedelic Conference: Innovative Approaches in Mental Health: Achievements and Challenges of Psychedelic Assisted Therapy will take place next Saturday, November 19. The meeting, organized by the Psychedelic Association Fuerteventura, will bring together some of the leading voices in psychedelic research, including the Psychedelic Guides book series, official sponsors of the event. The event will include among the speakers the scientific supervisor of the book series, José Carlos Bouso, as well as the author of Tu Cerebro con Psicodélicos, Genís Oña, and the legal advisor of the collection, Francisco Azorín.
Jose Carlos Bouso, scientific director of the Psychonaut Guides book series, has published a new study that aims to determine the effect of THC and CBD on social cognition skills, testing how CBD may counteract the possible effects of THC on these abilities. The hypothesis stated that participants under the effects of THC would show lower social cognition skills, and co-administration of THC-CBD would counteract these effects. In order to prove this, the authors designed a contextual, naturalistic, randomized, double-blind, placebo-controlled, crossover study to test the acute neuropsychological effects of vaporizing different types of cannabis extracts.
DMT (dimethytriptamine) is a natural psychoactive compound of the hallucinogen class, present in varying amounts in many plants, such as mimosas, acacias, mimosas or chacrunas. Traces of DMT can also be found in some mammalian organisms, although its function in our body is still unknown. DMT belongs to the chemical family of tryptamines and is a very simple compound, very similar to tryptophan (a common amino acid in the diet).
In our book series Psychonaut Guides we talk in depth about the most commonly used traditional psychedelics, but there are also other psychedelics of less common use and, among them, some are legal under certain circumstances. Here are 5 legal psychedelic substances you may not have known about. 1. HAWAIIAN BABY WOODROSE Hawaiian Baby Woodrose (Argyreia nervosa) is a perennial climbing plant native to India, with large heart-shaped leaves and white stunted flowers.
LSD stands for lysergic acid diethylamide. It is a psychoactive substance, which means that it acts on the central nervous system. This results in a change in behavior and the way the user relates to the world around them. These effects occur because of the way LSD affects the action of a brain chemical called serotonin. This substance helps control mood, thinking, behavior, and the senses. As Anton Gomez-Escolar tells us in the Essential Guide to the Psychedelic Renaissance, LSD was originally used as a psychotomimetic.
23 years ago Portugal decriminalized the consumption of narcotics. Contrary to what many expected at the time, this measure brought about a reduction in the consumption of substances such as heroin or cocaine, as well as a drop in the rate of HIV patients. Source: Portugal’s Parliament discusses comprehensive regulation of cannabis (https://canamo.net/noticiasimundo/el-parlamento-de-portugal-discute-la-regulacion-integral-del-cannabis) After the end of the dictatorship, a countercultural movement swept Portugal. And, as with much of the countercultural movements in the West after World War II, this wave was accompanied by a boom in the consumption of different types of substances.
We usually talk about the potential positive effects of psychedelic substances, however, it is important to keep in mind that these potential positive effects of psychedelic substances usually have an important psychological burden. That is why the psychological variables of person and context are especially crucial to not only make this type of experience as risk-free as possible, but also to turn it into a positive and, hopefully, transcendental experience.
As Antón Gómez-Escolar tells us in his Essential Guide to the Psychedelic Renaissance, throughout history, psilocybin mushrooms have had various religious, ritual and shamanistic uses. Nowadays, its use can be associated with recreational, spiritual, self-knowledge contexts and, therapeutically, it is investigated for the treatment of depression, anxiety, post-traumatic stress disorder, addictions or obsessive-compulsive disorder. But, how exactly does psilocybin act in our brain?? Antón Gómez-Escolar answers this question in his book, from which the information in this article is taken.
We recently heard the news of the release of the first trailer for Netflix’s new four-part documentary series ‘How to Change Your Mind’, based on Michael Pollan’s best-seller. With the mainstream world every day more immersed in the Psychedelic Renaissance, and awaiting regularization and legalization of the therapeutic use of these substances, in this post we have collected three legal psychedelic substances, with information about them extracted from the Essential Guide to the Psychedelic Renaissance, by Antón Gómez-Escolar, indicating in which countries and under what circumstances they are legal:
The first trailer for Netflix’s new four-part documentary series How to Change Your Mind has been released. New York Times best-selling author Michael Pollan’s 2018 book How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence is being adapted by Academy Award winner Alex Gibney. The documentary series, like the book, aims to inform viewers about a lesser-known side effect of some psychedelic drugs.
The idea of banning all “recreational” use of certain psychoactive substances was driven by a growing influence of Anglo-American Christian Puritanism and the temperance movement against alcohol in the late temperance movement against alcohol in the late nineteenth and early twentieth centuries, which in the United States also led to the prohibition of alcohol in the United States between 1920 and 1933. The campaign for prohibition was also fueled by racist sentiments toward by racist sentiments toward immigrants from China and Mexico, who used opiates and cannabis.
According to the World Health Organization (WHO), around the world there are 450 million people suffering from mental disorders and estimates that one in four people in the world will suffer, at some point in their lives, some mental disorder. Faced with this panorama and the lack of success in the treatment of some of the diseases, several researchers have resorted to look for other alternatives, among them, the use of psychedelics.
The Psychedelic Renaissance promises to revolutionize mental health through the use of psychedelics, but what exactly are psychedelics? The relationship between psychedelics and mental health has been studied since the 1940s. As we discussed in our post on the Psychedelic Renaissance, the excess of uncontrolled recreational use and a campaign to discredit the cultural movement to which they were linked caused research on their effects on mental health to be abandoned in most universities.
Pharmacology and neuroscience of psilocybin, DMT, LSD, MDMA or mescaline. “When I first approached psychedelic drugs, I knew instantly that my life was changed.” So begins Your Brain with Psychedelics, by Genís Oña, psychologist and pharmacologist and researcher at ICEERS (International Center for Ethnobotanical Education, Research, and Service). That change in his life, as a transcendental before and after, is one of the multiple themes explored in Your Brain with Psychedelics.
The Psychonaut Guides are now available in Amazon and Apple Books. The Essential Guide to the Psychedelic Renaissance, the first title that opens the book series, will introduce us to the exciting world of psychedelics by the hand of Antón Gómez-Escolar. This title is ideal whether you are approaching the Psychedelic Renaissance movement for the first time or you are passionate about this world, as it brings together the history, neuroscience, legality, therapeutic applications and harm reduction methods of the most promising psychedelic drugs for science.
The first books of PsychonautGuides.com have been released. Psychonaut Guides launches a series of books with a scientific approach for those who want to explore and discover the exciting world of hallucinogens, their potential and applications as part of the so-called Psychedelic Renaissance. Opening this collection on the Psychedelic Renaissance, we have the book by Antón Gómez-Escolar, “Essential Guide to the Psychedelic Renaissance”, which presents the history, neuroscience, legality, therapeutic applications and harm reduction of the most promising psychedelic drugs for science, as an introduction to this revolution that is beginning to spread around the world.
In the last few days two presentations of the first three books that will open the Psychonaut Guides collection have taken place in the United States. The first presentation in the United States has taken place in Boston and the second one in New York. Both events had an excellent reception among the participants, who were able to obtain some copies of the books, as you can start to see in the social networks, and have an interactive talk about the psychedelic world.
In the coming weeks the first three books of the PsychonautGuides.com catalogue will be available. The launch will be made in conjunction with the PsychonautGuides.com website and the titles will be available in English and Spanish, as well as in full color or B&W versions. Digital versions of the books will available in Amazon, Google Books and many other selling channels. The first introductory book to the collection will be “Essential Guide to the Psychedelic Renaissance”, by Antón Gómez-Escolar.
Copyright © 2022 Argonowta; all rights reserved.
Template by Bootstrapious. Ported to Hugo by DevCows.
